Showing results (31-40 of 201) with videos related to

Sort By:
Pageof 21
Current Opinion in Oncology|April 3, 1999
Reinventing bone marrow transplantation: reducing toxicity using nonmyeloablative, preparative regimens and induction of graft-versus-malignancyR Champlin, I Khouri, S Kornblau, et al.
Hematology (Amsterdam, Netherlands)|June 15, 2007
Bortezomib in combination with thalidomide-dexamethasone for previously untreated multiple myelomaM Wang, S Giralt, K Delasalle, et al.
Leukemia & Lymphoma|August 1, 1994
Leukemia cutis in acute promyelocytic leukemia: report of three cases after treatment with all-trans retinoic acidS Giralt, S O'Brien, E Weeks, et al.
Transplantation|July 1, 1986
Cure of malignant lymphoma in dogs with peripheral blood stem cell transplantationF R Appelbaum, H J Deeg, R Storb, et al.
American Journal of Hematology|January 10, 1998
Allogeneic marrow transplantation for myeloproliferative disorders other than chronic myelogenous leukemia: review of forty casesD Przepiorka, S Giralt, I Khouri, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 13, 1998
Lymphocytic gastritis resembling graft-vs.-host disease following autologous hematopoietic cell transplantationS P Tzung, R C Hackman, D M Hockenbery, et al.
Bone Marrow Transplantation|June 1, 2004
Clinical outcomes with intensive therapy for patients with primary resistant multiple myelomaR Alexanian, D Weber, K Delasalle, et al.
Cancer|October 24, 2000
Therapeutic choices in younger patients with chronic myelogenous leukemiaH M Kantarjian, F J Giles, S O'Brien, et al.
Bone Marrow Transplantation|December 12, 2002
Alemtuzumab (Campath-1H) for treatment of lymphoid malignancies in the age of nonmyeloablative conditioning?G Hale, S Slavin, J M Goldman, et al.
Bone Marrow Transplantation|July 5, 2001
Impact of complete remission with intensive therapy in patients with responsive multiple myelomaR Alexanian, D Weber, S Giralt, et al.
Pageof 21